- Home
- WIX vs BBIO Comparison
WIX vs BBIO Comparison
Compare WIX & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIX
- BBIO
- Stock Information
- Founded
- WIX 2006
- BBIO 2015
- Country
- WIX Israel
- BBIO United States
- Employees
- WIX N/A
- BBIO N/A
- Industry
- WIX Computer Software: Programming Data Processing
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- WIX Technology
- BBIO Health Care
- Exchange
- WIX Nasdaq
- BBIO Nasdaq
- Market Cap
- WIX 10.1B
- BBIO 9.4B
- IPO Year
- WIX 2013
- BBIO 2019
- Fundamental
- Price
- WIX $138.82
- BBIO $54.66
- Analyst Decision
- WIX Strong Buy
- BBIO Strong Buy
- Analyst Count
- WIX 19
- BBIO 16
- Target Price
- WIX $214.58
- BBIO $64.44
- AVG Volume (30 Days)
- WIX 2.0M
- BBIO 2.0M
- Earning Date
- WIX 11-19-2025
- BBIO 11-11-2025
- Dividend Yield
- WIX N/A
- BBIO N/A
- EPS Growth
- WIX 123.39
- BBIO N/A
- EPS
- WIX 2.81
- BBIO N/A
- Revenue
- WIX $1,868,709,000.00
- BBIO $235,812,000.00
- Revenue This Year
- WIX $14.22
- BBIO $115.46
- Revenue Next Year
- WIX $13.53
- BBIO $65.03
- P/E Ratio
- WIX $49.08
- BBIO N/A
- Revenue Growth
- WIX 13.04
- BBIO 7.62
- 52 Week Low
- WIX $114.89
- BBIO $21.72
- 52 Week High
- WIX $247.11
- BBIO $55.32
- Technical
- Relative Strength Index (RSI)
- WIX 37.66
- BBIO 61.71
- Support Level
- WIX $151.03
- BBIO $52.97
- Resistance Level
- WIX $180.99
- BBIO $55.33
- Average True Range (ATR)
- WIX 8.76
- BBIO 1.55
- MACD
- WIX -5.50
- BBIO 0.23
- Stochastic Oscillator
- WIX 10.85
- BBIO 95.04
About WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.